December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Re-Treatment with Diode Laser Photocoagulation for Severe Retinopathy of Prematurity: Indications and Results
Author Affiliations & Notes
  • DK Wallace
    University of North Carolina Chapel Hill NC
  • SF Freedman
    Duke University Durham NC
  • DK Coats
    Baylor College of Medicine Houston TX
  • DT Sprunger
    Indiana University Indianapolis IN
  • SE Brooks
    Augusta GA
  • Footnotes
    Commercial Relationships   D.K. Wallace, None; S.F. Freedman, None; D.K. Coats, None; D.T. Sprunger, None; S.E. Brooks, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4014. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      DK Wallace, SF Freedman, DK Coats, DT Sprunger, SE Brooks; Re-Treatment with Diode Laser Photocoagulation for Severe Retinopathy of Prematurity: Indications and Results . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4014.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: In some cases of severe retinopathy of prematurity (ROP), a second diode laser treatment of the same eye is necessary. Indications for laser re-treatment and results in these cases have not previously been reported. Methods: Records were reviewed from all patients who received a second laser treatment for ROP on at least one eye at one of five centers over the past 4-7 years. Indications for re-treatment included skip areas, persistent plus disease and/or stage 3, and progression of disease. An unfavorable anatomic outcome was defined, as in the CRYO-ROP study, as a retinal fold through the macula, a retinal detachment in zone I, or a retrolental mass. Results: Of 36 eyes in 26 patients, 31 (86%) had a favorable anatomic outcome and 5 (14%) had an unfavorable outcome. The mean interval between first and second treatment was 16 days (range 4-68). The mean number of laser spots at first treatment was 1675 (1319-2600) in zone I eyes and 1093 (300-1929) in zone II eyes. The mean number of spots at second treatment was 693 (157-1842) in zone I eyes and 364 (100-1274) in zone II eyes. Conclusion: When an eye with severe ROP fails to regress after laser treatment, prompt re-treatment directed at untreated or lightly treated avascular retina results in a favorable anatomic outcome in most cases.

Keywords: 572 retinopathy of prematurity • 454 laser 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.